Search research articles
Contact Us
Filters
Showing results (181-190 of 267) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival
Wen-Ting Liao, Li-Bing Song, Hui-Zhong Zhang, et al.
Nature Communications
|
November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Frontiers in Oncology
|
September 25, 2020
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma
Qi-Wen Li, Bo Qiu, Wan-Ming Hu, et al.
Plos One
|
November 8, 2007
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy
Jiang Li, Xue-hui Zeng, Hao-yuan Mo, et al.
Oncotarget
|
October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
Cell Death & Disease
|
September 2, 2016
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
Wen-Feng Hua, Qian Zhong, Tian-Liang Xia, et al.
Journal of Virology
|
March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>
Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Cancer Research
|
January 21, 2006
A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma
Ri-Cheng Jiang, Hai-De Qin, Mu-Sheng Zeng, et al.
Nature Communications
|
June 21, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
Ling Zhong, Wanlin Zhang, Hong Liu, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 267) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival
Wen-Ting Liao, Li-Bing Song, Hui-Zhong Zhang, et al.
Nature Communications
|
November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Frontiers in Oncology
|
September 25, 2020
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma
Qi-Wen Li, Bo Qiu, Wan-Ming Hu, et al.
Plos One
|
November 8, 2007
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy
Jiang Li, Xue-hui Zeng, Hao-yuan Mo, et al.
Oncotarget
|
October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
Cell Death & Disease
|
September 2, 2016
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma
Wen-Feng Hua, Qian Zhong, Tian-Liang Xia, et al.
Journal of Virology
|
March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>
Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Cancer Research
|
January 21, 2006
A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma
Ri-Cheng Jiang, Hai-De Qin, Mu-Sheng Zeng, et al.
Nature Communications
|
June 21, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
Ling Zhong, Wanlin Zhang, Hong Liu, et al.
Page
of 27